<VariationArchive VariationID="371029" VariationName="NM_000543.5(SMPD1):c.151_154del (p.Asp51fs)" VariationType="Deletion" Accession="VCV000371029" Version="11" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-03-30" DateCreated="2017-01-06" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="357977" VariationID="371029">
      <GeneList>
        <Gene Symbol="SMPD1" FullName="sphingomyelin phosphodiesterase 1" GeneID="6609" HGNC_ID="HGNC:11120" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="6390474" stop="6394996" display_start="6390474" display_stop="6394996" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="6411643" stop="6416227" display_start="6411643" display_stop="6416227" Strand="+" />
          </Location>
          <OMIM>607608</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000543.5(SMPD1):c.151_154del (p.Asp51fs)</Name>
      <CanonicalSPDI>NC_000011.10:6390746:CTGACT:CT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="6390747" stop="6390750" display_start="6390747" display_stop="6390750" variantLength="4" positionVCF="6390746" referenceAlleleVCF="TCTGA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="6411977" stop="6411980" display_start="6411977" display_stop="6411980" variantLength="4" positionVCF="6411976" referenceAlleleVCF="TCTGA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>D51fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000543.4" sequenceAccession="NM_000543" sequenceVersion="4" change="c.151_154del">
            <Expression>NM_000543.4:c.151_154del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.6390749_6390752del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.6390749_6390752del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.6411979_6411982del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.6411979_6411982del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011780.1" sequenceAccession="NG_011780" sequenceVersion="1" change="g.5325_5328del">
            <Expression>NG_011780.1:g.5325_5328del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000543.5" sequenceAccession="NM_000543" sequenceVersion="5" change="c.151_154del" MANESelect="true">
            <Expression>NM_000543.5:c.151_154del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000534.3" sequenceAccession="NP_000534" sequenceVersion="3" change="p.Asp51fs">
            <Expression>NP_000534.3:p.Asp51fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001007593.3" sequenceAccession="NM_001007593" sequenceVersion="3" change="c.151_154del">
            <Expression>NM_001007593.3:c.151_154del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001007594.2" sequenceAccession="NP_001007594" sequenceVersion="2" change="p.Asp51fs">
            <Expression>NP_001007594.2:p.Asp51fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318087.2" sequenceAccession="NM_001318087" sequenceVersion="2" change="c.151_154del">
            <Expression>NM_001318087.2:c.151_154del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305016.1" sequenceAccession="NP_001305016" sequenceVersion="1" change="p.Asp51fs">
            <Expression>NP_001305016.1:p.Asp51fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318088.2" sequenceAccession="NM_001318088" sequenceVersion="2" change="c.-811_-808del">
            <Expression>NM_001318088.2:c.-811_-808del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365135.2" sequenceAccession="NM_001365135" sequenceVersion="2" change="c.151_154del">
            <Expression>NM_001365135.2:c.151_154del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001352064.1" sequenceAccession="NP_001352064" sequenceVersion="1" change="p.Asp51fs">
            <Expression>NP_001352064.1:p.Asp51fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_027400.3" sequenceAccession="NR_027400" sequenceVersion="3" change="n.276_279del">
            <Expression>NR_027400.3:n.276_279del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_134502.2" sequenceAccession="NR_134502" sequenceVersion="2" change="n.276_279del">
            <Expression>NR_134502.2:n.276_279del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16041473" DB="ClinGen" />
        <XRef Type="rs" ID="1057516949" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000543.5(SMPD1):c.151_154del (p.Asp51fs) AND Niemann-Pick disease, type A" Accession="RCV000411564" Version="6">
        <ClassifiedConditionList TraitSetID="758">
          <ClassifiedCondition DB="MedGen" ID="C0268242">Niemann-Pick disease, type A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-09-07" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000543.5(SMPD1):c.151_154del (p.Asp51fs) AND multiple conditions" Accession="RCV001067896" Version="5">
        <ClassifiedConditionList TraitSetID="9472">
          <ClassifiedCondition DB="MedGen" ID="C0268242">Niemann-Pick disease, type A</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268243">Niemann-Pick disease, type B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-07" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2017-01-06" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12369017</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15221801</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24718843</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/645a8e96-ac3f-475c-adf6-e9281d165107</URL>
        </Citation>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9472" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5650" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type A</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+A/5226" DB="Genetic Alliance" />
                <XRef ID="52165006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELIN LIPIDOSIS</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELINASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7206" />
                <XRef ID="7206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77292" DB="Orphanet" />
              <XRef ID="C0268242" DB="MedGen" />
              <XRef ID="MONDO:0009756" DB="MONDO" />
              <XRef Type="MIM" ID="257200" DB="OMIM" />
            </Trait>
            <Trait ID="3636" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type B</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+B/5227" DB="Genetic Alliance" />
                <XRef ID="39390005" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10729" />
                <XRef ID="10729" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77293" DB="Orphanet" />
              <XRef ID="C0268243" DB="MedGen" />
              <XRef ID="MONDO:0011871" DB="MONDO" />
              <XRef Type="MIM" ID="607616" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="758" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5650" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type A</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+A/5226" DB="Genetic Alliance" />
                <XRef ID="52165006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELIN LIPIDOSIS</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELINASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7206" />
                <XRef ID="7206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77292" DB="Orphanet" />
              <XRef ID="C0268242" DB="MedGen" />
              <XRef ID="MONDO:0009756" DB="MONDO" />
              <XRef Type="MIM" ID="257200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2805128" SubmissionDate="2020-03-09" DateLastUpdated="2022-02-02" DateCreated="2020-07-19">
        <ClinVarSubmissionID localKey="645a8e96-ac3f-475c-adf6-e9281d165107|Orphanet:ORPHA77292" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001422717" DateUpdated="2022-02-02" DateCreated="2020-07-19" Type="SCV" Version="2" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24718843</ID>
          </Citation>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/645a8e96-ac3f-475c-adf6-e9281d165107</URL>
          </Citation>
          <Comment>The p.Asp51LeufsTer25 variant in SMPD1 (also known as p.Asp49LeufsTer25 due to a difference in cDNA numbering) has been reported in one Cambodian individual with Niemann-Pick disease (PMID: 24718843) and has been identified in 0.006% (1/15898) of African chromosomes and 0.001% (1/112280) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs1057516949). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (VariationID: 371029) as likely pathogenic by Counsyl. This variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at position 51 and leads to a premature termination codon 25 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the SMPD1 gene is an established disease mechanism in autosomal recessive Niemann-Pick disease. The phenotype of an individual compound heterozygous for this variant is highly specific for Niemann-Pick disease based on acid sphingomyelinase activity being &lt;10% of normal, consistent with disease (PMID: 24718843). In summary, this variant meets criteria to be classified as pathogenic for Niemann-Pick disease in an autosomal recessive manner based on the prediction that it will cause loss of function, the phenotype of an individual with the variant being highly specific for disease, and the low frequency of the variant in the general population. ACMG/AMP Criteria applied: PVS1, PM2, PP4 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Abbrev="ACMG, 2015" Type="practice guideline">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000543.4(SMPD1):c.151_154delGACT</Name>
            <Name>p.Asp51Leufs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.10:g.6390749_6390752delGACT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA77292" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6906750</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="950233" SubmissionDate="2016-11-23" DateLastUpdated="2022-12-24" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="455247|OMIM:257200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000486483" DateUpdated="2022-12-24" DateCreated="2017-01-06" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24718843</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rb7nm21v/ar_xl2015criteria.pdf</URL>
            <CitationText>mdi-5618_320494_Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015).pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.4:c.151_154delGACT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="257200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Counsyl2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7858620" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000543.5:c.151_154del|OMIM:257200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004203220" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.5:c.151_154del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="257200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2398603" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4891011|MedGen:C0268243;C0268242" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001232979" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24718843</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12369017</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15221801</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 371029). This premature translational stop signal has been observed in individual(s) with acid sphingomyelinase-deficient Niemann-Pick disease (PMID: 24718843). This variant is present in population databases (no rsID available, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Asp51Leufs*25) in the SMPD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMPD1 are known to be pathogenic (PMID: 12369017, 15221801).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.6411977_6411980del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268243" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268242" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2805128" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA77292" MappingRef="Orphanet">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2398603" TraitType="Disease" MappingType="XRef" MappingValue="C0268242" MappingRef="MedGen">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="950233" TraitType="Disease" MappingType="XRef" MappingValue="257200" MappingRef="OMIM">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2398603" TraitType="Disease" MappingType="XRef" MappingValue="C0268243" MappingRef="MedGen">
        <MedGen CUI="C0268243" Name="Niemann-Pick disease, type B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7858620" TraitType="Disease" MappingType="XRef" MappingValue="257200" MappingRef="OMIM">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

